Log in

NYSE:LHLaboratory Corp. of America Stock Price, Forecast & News

+3.24 (+1.94 %)
(As of 07/3/2020 04:00 PM ET)
Today's Range
Now: $170.27
50-Day Range
MA: $169.90
52-Week Range
Now: $170.27
Volume1.07 million shs
Average Volume844,736 shs
Market Capitalization$16.55 billion
P/E Ratio52.72
Dividend YieldN/A
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, LabCorp Diagnostics (LCD) and Covance Drug Development. It offers various clinical laboratory tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually-transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides testing services in the areas of women's health, allergy, diagnostic genetics, cardiovascular disease, infectious disease, endocrinology, oncology, coagulation, pharmacogenetics, toxicology, and medical drug monitoring; and esoteric testing, cancer diagnostics, and other complex procedures. In addition, it provides technology-enabled solutions, including a suite of applications to enable patients, healthcare providers, health systems, accountable care organizations, and insurers with convenient and secure access to LCD's data and services, as well as billing for laboratory services. Further, it offers end-to-end drug development, medical device, and diagnostic development solutions from research to clinical development and commercial market access. The company primarily serves managed care organizations, biopharmaceutical companies, physicians and other healthcare providers, hospitals and health systems, governmental agencies, employers, patients and consumers, contract research organizations, academic institutions, and independent clinical laboratories. Laboratory Corporation of America Holdings has collaborations with the Boston University, Columbia University, Duke University, Johns Hopkins University, The Mount Sinai Hospital, the University of Tennessee, Yale University, and QIAGEN N.V. The company was founded in 1971 and is headquartered in Burlington, North Carolina.
Read More
Laboratory Corp. of America logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.4Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.60 out of 5 stars

Industry, Sector and Symbol

Industry Medical laboratories
Sub-IndustryHealth Care Services



Sales & Book Value

Annual Sales$11.55 billion
Cash Flow$19.44 per share
Book Value$77.93 per share


Net Income$823.80 million


Market Cap$16.55 billion
Next Earnings Date7/23/2020 (Estimated)

Receive LH News and Ratings via Email

Sign-up to receive the latest news and ratings for LH and its competitors with MarketBeat's FREE daily newsletter.

Laboratory Corp. of America (NYSE:LH) Frequently Asked Questions

How has Laboratory Corp. of America's stock been impacted by COVID-19 (Coronavirus)?

Laboratory Corp. of America's stock was trading at $158.99 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, LH shares have increased by 7.1% and is now trading at $170.27. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Laboratory Corp. of America?

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Laboratory Corp. of America in the last year. There are currently 4 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Laboratory Corp. of America.

When is Laboratory Corp. of America's next earnings date?

Laboratory Corp. of America is scheduled to release its next quarterly earnings announcement on Thursday, July 23rd 2020. View our earnings forecast for Laboratory Corp. of America.

How were Laboratory Corp. of America's earnings last quarter?

Laboratory Corp. of America Holdings (NYSE:LH) issued its earnings results on Wednesday, April, 29th. The medical research company reported $2.37 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $1.95 by $0.42. The medical research company earned $2.82 billion during the quarter, compared to analysts' expectations of $2.73 billion. Laboratory Corp. of America had a return on equity of 15.03% and a net margin of 2.77%. The firm's revenue for the quarter was up 1.2% on a year-over-year basis. During the same period last year, the business posted $2.62 earnings per share. View Laboratory Corp. of America's earnings history.

What price target have analysts set for LH?

15 brokers have issued 12-month target prices for Laboratory Corp. of America's stock. Their forecasts range from $170.00 to $244.00. On average, they anticipate Laboratory Corp. of America's stock price to reach $203.19 in the next twelve months. This suggests a possible upside of 19.3% from the stock's current price. View analysts' price targets for Laboratory Corp. of America.

Has Laboratory Corp. of America been receiving favorable news coverage?

Press coverage about LH stock has trended negative this week, InfoTrie Sentiment Analysis reports. The research firm scores the sentiment of media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Laboratory Corp. of America earned a media sentiment score of -2.1 on InfoTrie's scale. They also assigned news articles about the medical research company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the next few days. View the latest news about Laboratory Corp. of America.

Who are some of Laboratory Corp. of America's key competitors?

What other stocks do shareholders of Laboratory Corp. of America own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Laboratory Corp. of America investors own include Gilead Sciences (GILD), Johnson & Johnson (JNJ), Micron Technology (MU), Amgen (AMGN), Intel (INTC), Pfizer (PFE), AbbVie (ABBV), Cisco Systems (CSCO), NVIDIA (NVDA) and Abbott Laboratories (ABT).

Who are Laboratory Corp. of America's key executives?

Laboratory Corp. of America's management team includes the following people:
  • Mr. David P. King, Chairman, CEO & Pres (Age 63)
  • Mr. Glenn A. Eisenberg, CFO & Exec. VP (Age 58)
  • Mr. F. Samuel Eberts III, Chief Legal Officer, Chief Compliance Officer, Sr. VP & Sec. (Age 59)
  • Mr. John D. Ratliff, Chief Exec. Officer of Covance Drug Devel. (Age 59)
  • Dr. Michelle Abelson, Laboratory Director of Operations

What is Laboratory Corp. of America's stock symbol?

Laboratory Corp. of America trades on the New York Stock Exchange (NYSE) under the ticker symbol "LH."

Who are Laboratory Corp. of America's major shareholders?

Laboratory Corp. of America's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Nelson Van Denburg & Campbell Wealth Management Group LLC (0.00%). Company insiders that own Laboratory Corp. of America stock include David P King, Der Vaart Sandra D Van, Glenn A Eisenberg, Jean-Luc Belingard, Judith C Seltz, Kerrii B Anderson, Lance Berberian, Lisa J Uthgenannt, Mark S Schroeder, Peter J Wilkinson, R Sanders Williams and Robert E Mittelstaedt Jr. View institutional ownership trends for Laboratory Corp. of America.

Which institutional investors are selling Laboratory Corp. of America stock?

LH stock was sold by a variety of institutional investors in the last quarter, including Nelson Van Denburg & Campbell Wealth Management Group LLC. Company insiders that have sold Laboratory Corp. of America company stock in the last year include David P King, Der Vaart Sandra D Van, Glenn A Eisenberg, Jean-Luc Belingard, Kerrii B Anderson, Lance Berberian, Lisa J Uthgenannt, Mark S Schroeder, Peter J Wilkinson, and R Sanders Williams. View insider buying and selling activity for Laboratory Corp. of America.

How do I buy shares of Laboratory Corp. of America?

Shares of LH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Laboratory Corp. of America's stock price today?

One share of LH stock can currently be purchased for approximately $170.27.

How big of a company is Laboratory Corp. of America?

Laboratory Corp. of America has a market capitalization of $16.55 billion and generates $11.55 billion in revenue each year. The medical research company earns $823.80 million in net income (profit) each year or $11.32 on an earnings per share basis. Laboratory Corp. of America employs 65,000 workers across the globe.

What is Laboratory Corp. of America's official website?

The official website for Laboratory Corp. of America is www.labcorp.com.

How can I contact Laboratory Corp. of America?

Laboratory Corp. of America's mailing address is 358 South Main Street, BURLINGTON NC, 27215. The medical research company can be reached via phone at 336-229-1127 or via email at [email protected]

This page was last updated on 7/5/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.